ロード中...
A Single Institution Experience of Incorporation of Cisplatin into Adjuvant Chemotherapy for Patients With Triple-Negative Breast Cancer of Unknown BRCA Mutation Status
The clinical benefit of adding platinum to adjuvant chemotherapy for patients with triple-negative breast cancer (TNBC) has not been well investigated, although it was associated an improved response rate in neoadjuvant setting. We retrospectively analyzed the time to tumor progression (TTP) and ove...
保存先:
| 出版年: | Clin Med Insights Oncol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6104219/ https://ncbi.nlm.nih.gov/pubmed/30150877 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1179554918794672 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|